M

Marta Compte

Recombinant Antibody Technology (United Kingdom)

ORCID: 0000-0002-7138-9266

116 papers and 2.4k citations.

PubIndex Score35Top 65% · mid-careerHow it's scored

116Publications

2.4kTotal Citations

First publication: 2006First senior author: 2014

Top publicationsby citations

A tumor-targeted trimeric 4-1BB-agonistic antibody induces potent anti-tumor immunity without systemic toxicity

Marta Compte, Luis Álvarez‐Vallina|Nature Communications|2018

Cited by 143

Indexing the rest of 116 publications…